COST EFFECTIVENESS OF DAPAGLIFLOZIN/METFORMIN VERSUS GLIBENCLAMIDE/METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN CHILE
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1305
https://www.valueinhealthjournal.com/article/S1098-3015(16)01373-5/fulltext
Title :
COST EFFECTIVENESS OF DAPAGLIFLOZIN/METFORMIN VERSUS GLIBENCLAMIDE/METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN CHILE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01373-5&doi=10.1016/j.jval.2016.03.1305
First page :
A204
Section Title :
Diabetes/Endocrine Disorders - Cost Studies
Open access? :
No
Section Order :
646